[Follow-up treatment of myocardial infarct].
D000925:Anticoagulants / Q000627:therapeutic use; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003920:Diabetes Mellitus / Q000517:prevention & control; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D013328:Strophanthins / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000925:Anticoagulants; D004071:Digitalis Glycosides; D004967:Estrogens; D013328:Strophanthins; D014665:Vasodilator Agents
Nachbehandlung nach Herzinfarkt.